Vincent T. T. Ho, M.D.

Doctor
Dana-Farber Cancer Institute

Disclosure(s): Alexion Pharmaceuticals: Advisor/Consultant; Allovir: Advisor/Consultant, DSMC; Jazz Pharmaceuticals: Grant/Research Support; Omeros: Advisor/Consultant

Poster(s):

• 2098 - Cytomegalovirus (CMV) Infection Following Hematopoietic Cell Transplantation (HCT) with Post-transplant Cyclophosphamide (PTCy): Outcomes in Haploidentical versus Matched or Mismatched Unrelated Donor (MUD/MMURD) Allografts
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET